Displaying drugs 9876 - 9900 of 12647 in total
6-Hydroxy-5-undecyl-4,7-benzothiazoledione
Experimental
Flaviolin
Experimental
L-Leucyl-Hydroxylamine
Experimental
2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE
Experimental
Gossypol
Gossypol has been used in trials studying the treatment of Non-small Cell Lung Cancer.
Investigational
Matched Description: … Gossypol has been used in trials studying the treatment of Non-small Cell Lung Cancer. …
Pheneturide
Experimental
(4S)-4-hydroxy-3,4-dihydro-2(1H)-pyrimidinone
Experimental
Cadralazine
Experimental
DOTMP HO-166
DOTMP HO-166 is used in skeletal targeted radiotherapy (STR). SRT is designed to be used in combination with high-dose chemotherapy producing a direct therapeutic effect on the tumor sites in the bone plus a general bone-marrow effect to destroy myeloma cells in the bone marrow. It is an experimental therapy...
Investigational
Propamidine
Experimental
Investigational
2,5-Diaminopyrimidin-4,6-diol
Experimental
Irosustat
Irosustat has been investigated for the treatment of Metastatic Breast Cancer and Locally Advanced Breast Cancer.
Investigational
Matched Description: … Irosustat has been investigated for the treatment of Metastatic Breast Cancer and Locally Advanced Breast …
2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE
Experimental
Dapoxetine
Dapoxetine is a selective serotonin reuptake inhibitor, for the treatment of premature ejaculation. In a phase II proof-of-concept study conducted by PPD, dapoxetine demonstrated a statistically significant increase in ejaculatory latency when compared to placebo. Alza submitted a NDA to the FDA for dapoxetine for the treatment of premature ejaculation...
Investigational
Matched Description: … Dapoxetine is a selective serotonin reuptake inhibitor, for the treatment of premature ejaculation. ... Alza submitted a NDA to the FDA for dapoxetine for the treatment of premature ejaculation in December ... In a phase II proof-of-concept study conducted by PPD, dapoxetine demonstrated a statistically significant …
Matched Categories: … Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome …
Matched Categories: … Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome …
Quinalizarin
Experimental
Cibenzoline
Experimental
(S)-Warfarin
Warfarin consists of a racemic mixture of two active enantiomers—R- and S- forms—each of which is cleared by different pathways. S-warfarin is 2-5 times more potent than the R-isomer in producing an anticoagulant response.
Experimental
Investigational
Matched Description: … Warfarin consists of a racemic mixture of two active enantiomers—R- and S- forms—each of which is cleared …
3,4-Dihydroxy-1-Methylquinolin-2(1h)-One
Experimental
Edratide
Edratide is under investigation in clinical trial NCT00203151 (A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus).
Investigational
Matched Iupac: … 2S)-1-[(carboxymethyl)carbamoyl]-2-methylbutyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid …
Matched Description: … Edratide in the Treatment of Lupus). ... investigation in clinical trial NCT00203151 (A Study to Evaluate the Tolerability, Safety and Effectiveness of …
Matched Description: … Edratide in the Treatment of Lupus). ... investigation in clinical trial NCT00203151 (A Study to Evaluate the Tolerability, Safety and Effectiveness of …
Ganglioside GM1
Investigational
Matched Iupac: … hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid …
Bis-Benzamidine
Experimental
Displaying drugs 9876 - 9900 of 12647 in total